Cytodyn Inc (CYDY)

[gestalt2]

I will also add that when I talked a week ago to Jody she stated that the process is very much controlled by the FDA. I now take this to mean, as you are assuming, is that mgmt is being very careful about what they PR/say publicly about anything. I don't think the FDA has anything to do with the warrant repricing situation but the lack of a CC or PR clarifying anything related to the trials likely does.

As for the warrant holders - could it be possible that some have more/less information related to the company and therefore the company has to be selective about which warrant holder can take the deal? Maybe some signed some sort of NDA or are insiders and can't risk insider trading if they exercise and are worried that they might?